Erasca
ERAS
154 hedge funds and large institutions have $307M invested in Erasca in 2025 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 48 reducing their positions, and 18 closing their positions.
93% more call options, than puts
Call options by funds: $29K | Put options by funds: $15K
50% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 18
5% more funds holding
Funds holding: 146 → 154 (+8)
0% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 48
2.48% less ownership
Funds ownership: 81.66% → 79.17% (-2.5%)
47% less capital invested
Capital invested by funds: $579M → $307M (-$272M)
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$5.46M |
| 2 |
AAA
Affinity Asset Advisors
New York
|
+$1.45M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.01M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$999K |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$858K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$7.36M |
| 2 |
State Street
Boston,
Massachusetts
|
-$4.17M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.51M |
| 4 |
Millennium Management
New York
|
-$1.64M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$1.55M |
ERAS Hedge Fund Activity: Q1 2025 in Review
154 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Erasca (ERAS) for Q1 2025, worth a combined $307M — down 47% from $579M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new ERAS positions and 18 closed out — a net gain of 9 holders — while 48 added to existing stakes and 48 trimmed.
The largest buyer was Frazier Life Sciences Management, adding an estimated $5.46M. The largest seller was Citadel Advisors, cutting an estimated $7.36M.
- 154 institutional investors held Erasca (ERAS) as of Q1 2025, up from 146 in Q4 2024.
- Funds reported $307M of Erasca stock for Q1 2025, down 47% quarter-over-quarter.
- 27 funds opened new Erasca positions in Q1 2025 and 18 closed out, a net change of +9 holders.
- The largest Erasca buyer in Q1 2025 was Frazier Life Sciences Management, an estimated $5.46M added.
- The largest Erasca seller in Q1 2025 was Citadel Advisors, an estimated $7.36M sold.
Based on aggregated 13F filings for Q1 2025.